aMoon (investor - Venture Capital)
See something wrong or missing? Let us know
Offices:Tel Aviv
aMoon is an Israel-based healthtech and life sciences venture fund
Average round investment:48.54M USD
Average number per year:1.5
Distribution:
2024 (1)2020 (2)
Portfolio companies:
Lyfegen
Sophia Genetics
MiNA Therapeutics



Mostly invests in:
Switzerland (2)
Health services (3)

3 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to aMoon
Name | Criteria | |
---|---|---|
![]() |
Bristol-Myers Squibb
79%
|
|
![]() |
Gimv
79%
|
|
![]() |
Hitachi Ventures
79%
|
|
![]() |
OrbiMed Advisors
79%
|
|
![]() |
Pfizer Venture Investments
79%
|
|
![]() |
Sanofi Ventures
79%
|
|
![]() |
Georgian
79%
|
|
![]() |
Cargill
79%
|
|
![]() |
SV Health Investors
79%
|
|
![]() |
Cleveland Avenue
79%
|
|